April 3, 2024
Tag: Multiple Myeloma and Amyloidosis Clinical Program
April 25, 2023
Multiple myeloma is a silent invader
Multiple myeloma is cancer of the immune system. Oncologist Sascha Tuchman, MD, MHS, shares what you need to know about the condition and treatment.
March 24, 2023
Oncology: Recap: MRD Negativity, Frailty, and Emerging Therapies in Multiple Myeloma
March 9, 2023
ASCO Post: Studies Focusing on Age- and Race-Related Disparities in Multiple Myeloma and Sickle Cell Disease
December 15, 2022
Studies identify barriers between doctors and their patients that limit clinical trial enrollment for Black people with blood cancers
Shakira Grant, MBBS, the studies’ principal investigator, shared the findings during oral presentations at the annual meeting of the American Society of Hematology (ASH) in New Orleans.
December 15, 2022
Study identifies health care access barriers for older adults with multiple myeloma and their caregivers
A study led by UNC Lineberger's Shakira Grant, MBBS, and colleagues found several barriers to high-quality cancer care for people with multiple myeloma and their caregivers.
November 10, 2022
Cancer Network: Evaluating MRD-Guided Therapy in Patients with NDMM
June 26, 2022
Hematologist focuses on multiple myeloma, amyloidosis
Sascha Tuchman, MD, MHS, specializes in hematology, and specifically multiple myeloma and amyloidosis. At UNC Lineberger, he collaborates with other UNC Lineberger clinicians and scientists, and works to cultivate the next generation of myeloma experts.
November 22, 2021
Grant receives $200,000 NIH grant to study impact of multiple myeloma on older adults, care partners
UNC Lineberger’s Shakira Grant, MBBS, was awarded a two-year research grant to study the illness and treatment experiences of older adults with multiple myeloma and their care partners.
May 2, 2021